HRTG Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Persist Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations ONL Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions Rentokil Initial RTO Q4 2025 Earnings EPS Miss Weighs on Shares as Margins Face Pressure Cybin Inc HELP Q1 2026 Earnings WiderthanExpected Loss Highlights Clinical Development Costs Mistras Group MG Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction